- Chromosomal Microarray (CMA-315K) (1)
- Chromosomal Microarray (CMA-315K)
- Karyotyping (KT)- Prenatal (1)
- Karyotyping (KT)- Prenatal
- Maternal Cell Contamination (MCC) (1)
- Maternal Cell Contamination (MCC)
Advanced Genetic Analysis for Prenatal Care: Karyotyping and Chromosomal Microarray (CMA)
The Advanced Genetic Analysis package offers a comprehensive prenatal assessment to ensure the well-being of your developing baby. This package combines two powerful genetic tests, Karyotyping and Chromosomal Microarray (CMA), to provide a thorough examination of the fetus’s chromosomes and detect any genetic abnormalities.
Karyotyping (KT) – Prenatal:
Karyotyping is a traditional cytogenetic test that examines the fetal chromosomes for structural and numerical anomalies. It helps identify conditions such as Down syndrome, Edwards syndrome, and Patau syndrome, providing essential information to guide pregnancy management and support the family in making informed decisions.
Chromosomal Microarray (CMA-315K):
CMA is a cutting-edge genetic test that provides high-resolution analysis of the fetal DNA for small genetic changes, including microdeletions and microduplications. CMA can detect a wider range of genetic disorders and provides more detailed information compared to traditional karyotyping.
Maternal Cell Contamination (MCC):
Maternal Cell Contamination testing ensures that the results obtained from the prenatal tests are accurate by confirming that the analyzed DNA comes primarily from the fetus and not the mother. This step helps prevent false results and ensures the reliability of the genetic findings.
The Advanced Genetic Analysis package is recommended for expectant parents seeking comprehensive insights into their baby’s genetic health. The combination of Karyotyping and Chromosomal Microarray offers a robust evaluation of chromosomal and genetic variations, enabling early detection and timely intervention if necessary.